Theuer says it expects to start enrolling patients in the trial at 25 sites in the US in the fourth quarter of 2020.
TRACON Pharmaceuticals approved by the FDA to begin sarcoma cancer therapy in humans
Quick facts: TRACON Pharmaceuticals
Price: 4.85 USD
Market Cap: $63.94 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of TRACON Pharmaceuticals named herein, including the promotion by the Company of TRACON Pharmaceuticals in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE